Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025

REDWOOD CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a top Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for the third quarter of fiscal 2025 year and (unaudited) ended December 31, 2024.

Read more at globenewswire.com